A Study of KN026-based Combination Therapy in HER2-positive Gastric Cancer
Shanghai JMT-Bio Inc.
Shanghai JMT-Bio Inc.
Shanghai Zhongshan Hospital
University of Cincinnati
RemeGen Co., Ltd.
Seattle Project Corporation
NRG Oncology
InnoPharmax Inc.
University of Birmingham
Australasian Gastro-Intestinal Trials Group
Gruppo Oncologico del Nord-Ovest
Tyme, Inc
CancerCare Manitoba
Ono Pharmaceutical Co. Ltd
Shanghai University of Traditional Chinese Medicine
Qilu Pharmaceutical Co., Ltd.
Hebei Medical University
Ruijin Hospital
ASLAN Pharmaceuticals
Ruijin Hospital
Ruijin Hospital
Odense University Hospital
Hebei Medical University
Hutchmed
University of Birmingham
Velindre NHS Trust
State Key Laboratory of Cancer Biology
Instituto Nacional de Cancer, Brazil
Medical Research Council
Ruijin Hospital
Fudan University
National Cancer Institute (NCI)
Wales Cancer Trials Unit
Fudan University
IRCCS San Raffaele
Fudan University
Australasian Gastro-Intestinal Trials Group